Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug

Cyclo Therapeutics

07/02/2025 15:56

** Shares of drug developer Cyclo Therapeutics  CYTH.O  rise
~40% to $1.08 - set for biggest single-day pct jump in nearly 4
years, if gains hold
    ** Preliminary data from a late-stage study shows 87% of
patients under the age of 3 with a rare genetic disorder saw
stabilization or improvement in disease progression after 24
weeks when treated with co's drug, trappsol cyclo - CYTH
    ** Co evaluating drug for treatment of Niemann-Pick Disease
Type C1, a condition where cholesterol builds up in cells,
causing damage and potentially premature death
    ** Co says it plans to release the trial data in H1 2025
    ** More than 64 mln shares traded, 1157 times their 25-day
moving avg
    ** CYTH shares fell 64.5% in 2024
 

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com;))